Stay updated with breaking news from Julia Ransohoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Triple-negative breast cancer patients who used antibiotics within three years of diagnosis have an increased risk of death, according to a study. The gut microbiome is a likely link.
Triple-negative breast cancer patients who take antibiotics within three years of diagnosis have a higher death risk, researchers report.
Women with triple-negative breast cancer who received multiple antibiotic prescriptions within three years after their cancer diagnosis were more likely to experience disease recurrence and to die from their cancer than those who took fewer courses of the drugs, according to a study by researchers at Stanford Medicine.